Literature DB >> 12902841

Ultrasonographic assessment of global cerebral blood volume in healthy adults.

Florian Doepp1, Stephan J Schreiber, Peter Brunecker, José M Valdueza.   

Abstract

The authors describe a new ultrasonographic method for analysis of global cerebral blood volume (CBV) and its application under controlled hyperventilation. CBV was determined as the product of global cerebral blood flow volume (CBF) and global cerebral circulation time. CBF was measured by duplex sonography and calculated as the sum of flow volumes in both internal carotid arteries and vertebral arteries. Extracranial Doppler assessed cerebral circulation time by determining the time interval of echo-contrast bolus arrival between internal carotid artery and contralateral internal jugular vein. Forty-four healthy volunteers (mean age 45 +/- 19 years, range 20-79 years) were studied. Mean CBV was 77 +/- 13 mL. CBV did not correlate with age, end-tidal carbon dioxide level, heart rate, or blood pressure. Hypocapnia was induced in 10 subjects by controlled hyperventilation. Mean reduction of end-tidal carbon dioxide values by 9 +/- 1 mm Hg led to a significant increase in cerebral circulation time (6.1 +/- 0.9 to 8.4 +/- 1.1 second, P < 0.0001) and a significant CBF decrease (742 +/- 85 to 526 +/- 77 mL/min, P < 0.0001), whereas CBV remained unchanged (75 +/- 6 to 73 +/- 10 mL).

Entities:  

Mesh:

Year:  2003        PMID: 12902841     DOI: 10.1097/01.WCB.0000071884.63724.69

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  2 in total

1.  Ultrasonographic measurement of cerebral blood flow, cerebral circulation time and cerebral blood volume in vascular and Alzheimer's dementia.

Authors:  Stephan J Schreiber; Florian Doepp; Eike Spruth; Ute A Kopp; José M Valdueza
Journal:  J Neurol       Date:  2005-09-12       Impact factor: 4.849

2.  Cerebral Blood Flow Volume Using Color Duplex Sonography in Patients With Fibromyalgia Syndrome.

Authors:  Arzu Kaya; Gürkan Akgöl; Arif Gülkesen; Ahmet Kürşad Poyraz; Tülay Yildirim; Murad Atmaca
Journal:  Arch Rheumatol       Date:  2017-10-13       Impact factor: 1.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.